Revolutionize the delivery of RNA & protein
We create unique therapeutic bacteria for unmet patient needs. Our current therapeutic focus includes pancreatic cancer, colorectal cancer, cervical cancer and liver diseases, while we continue to seek new medical applications. Industry collaboration is an important pillar of our strategy.
Redbiotec News
Swiss Nordic Bio Conference
Date: Feb 6, 2020 Location: Zürich We will attend this year's Swiss Nordic Bio Conference, and look forward to sharing [...]
Outlook 2020
We thank you for your trust and support in 2019 and we wish you all the best in the forthcoming [...]
Gene therapy expert Dr. Michele Calos joins the Scientific Advisory Board of Redbiotec
Redbiotec AG, a pioneer in living medicines, further expands its Scientific Advisory Board with the appointment of Professor Michele Calos, [...]
Redbiotec expands its Scientific Advisory Board with the appointment of Prof. Dr. Dr. Christoph U. Schoen
Redbiotec AG, a pioneer in living medicines, is pleased to announce the addition of Professor Christoph U. Schoen, MD, PhD [...]